# Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.

Study · id `cardio:ct-nct01311700` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01311700](<https://clinicaltrials.gov/study/NCT01311700>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01311700

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

## Technical summary

Registry record NCT01311700. Randomized; single masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 221 participants (enrolled count; ClinicalTrials.gov record NCT01311700, source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01311700, source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)
- Primary completion: 2012-10 (actual) (ClinicalTrials.gov record NCT01311700, source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)
- Completion: 2017-10 (actual) (ClinicalTrials.gov record NCT01311700, source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01311700, source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01311700-2018-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.
- Acronym: METOCARD-CNIC
- Condition: Myocardial Infarction
- Intervention (Drug): Injectable (i.v.) metoprolol tartrate (up to 15 mg).
- Lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Lead sponsor class: OTHER
- Collaborator: Ministerio de Sanidad, Servicios Sociales e Igualdad
- Collaborator class: OTHER\_GOV
- Collaborator: Fundación Mutua Madrileña
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Metoprolol (`cardio:metoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (`cardio:org-fundacion-centro-nacional-de-investigaciones-0f9f16`)
- Registry lists this organization as a collaborator: Ministerio de Sanidad, Servicios Sociales e Igualdad (`cardio:org-ministerio-de-sanidad-servicios-sociales-e-igualdad`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial (`cardio:pubmed-24002794`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) (`cardio:pubmed-24694530`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial (`cardio:pubmed-25129820`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial (`cardio:pubmed-30219400`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy) (`cardio:pubmed-32522198`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 763dbeaea2d44868db11624e40d2a0329ade1764f495ba396be6930cbf5f24a1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
